ArticleMolecular cancer2026

Identification of HSPE1 as a new actionable cancer vulnerability leads to an innovative and effective combination therapy for pancreatic ductal adenocarcinoma.

Julien Boudreault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.